Capital Investment Advisors LLC Sells 10,382 Shares of CVS Health Corporation $CVS

Key Points

• Capital Investment Advisors LLC sold 10,382 shares of CVS Health, reducing its stake by 11.7%, now holding 78,084 shares valued at approximately $5.39 million.
• CVS Health recently reported earnings of $1.81 per share, exceeding estimates, with revenue of $98.92 billion for the quarter, marking an 8.4% year-over-year increase.
• The company will pay a quarterly dividend of $0.665 on November 3rd, representing an annualized yield of 3.5% and a payout ratio of 74.30%.

Capital Investment Advisors LLC reduced its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 78,084 shares of the pharmacy operator's stock after selling 10,382 shares during the period. Capital Investment Advisors LLC's holdings in CVS Health were worth $5,386,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bell Investment Advisors Inc increased its stake in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC increased its position in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 202 shares in the last quarter. ORG Partners LLC raised its holdings in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 377 shares during the last quarter. Saudi Central Bank acquired a new position in CVS Health during the 1st quarter valued at about $34,000. Finally, Livelsberger Financial Advisory bought a new stake in CVS Health during the 2nd quarter worth approximately $35,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

Shares of CVS opened at $75.31 on Wednesday. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average price of $69.70 and a 200-day moving average price of $67.13. The company has a market cap of $95.52 billion, a PE ratio of 21.04, a price-to-earnings-growth ratio of 0.83 and a beta of 0.62. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $77.34.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same period in the previous year, the business posted $1.83 earnings per share. CVS Health's revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health's payout ratio is 74.30%.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the company's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.22% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Jefferies Financial Group upped their price target on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Cantor Fitzgerald reissued an "overweight" rating and set a $78.00 price target on shares of CVS Health in a research report on Tuesday, August 26th. Robert W. Baird raised shares of CVS Health from a "neutral" rating to an "outperform" rating and upped their price objective for the stock from $71.00 to $82.00 in a research report on Thursday, August 14th. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $67.00 to $79.00 in a research report on Monday, August 18th. Finally, Morgan Stanley upped their price objective on shares of CVS Health from $80.00 to $82.00 and gave the stock an "overweight" rating in a research report on Friday, August 1st. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and an average price target of $78.25.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.